Literature DB >> 2571786

Acute psychosis following mefloquine prophylaxis.

A Björkman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571786     DOI: 10.1016/s0140-6736(89)93029-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  [Use-risk consideration of anti-infective agents from the point of view of the licensing authority].

Authors:  W Christ; B Esch
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 2.  Risks and benefits of prophylactic antimalarial drugs.

Authors:  A Breckenridge
Journal:  BMJ       Date:  1989-10-28

Review 3.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 4.  CNS adverse events associated with antimalarial agents. Fact or fiction?

Authors:  P A Phillips-Howard; F O ter Kuile
Journal:  Drug Saf       Date:  1995-06       Impact factor: 5.606

5.  Idiosyncratic quinoline central nervous system toxicity: Historical insights into the chronic neurological sequelae of mefloquine.

Authors:  Remington L Nevin
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-04-05       Impact factor: 4.077

6.  Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients.

Authors:  Sue J Lee; Feiko O Ter Kuile; Ric N Price; Christine Luxemburger; François Nosten
Journal:  PLoS One       Date:  2017-02-13       Impact factor: 3.240

7.  Identification of a Syndrome Class of Neuropsychiatric Adverse Reactions to Mefloquine from Latent Class Modeling of FDA Adverse Event Reporting System Data.

Authors:  Remington L Nevin; Jeannie-Marie Leoutsakos
Journal:  Drugs R D       Date:  2017-03

8.  Behavioral effects of mefloquine in tail suspension and light/dark tests.

Authors:  John Michael Holden; Richard Slivicki; Rachel Dahl; Xia Dong; Matt Dwyer; Weston Holley; Crissa Knott
Journal:  Springerplus       Date:  2015-11-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.